{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:56:13Z","timestamp":1791194173450,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1124\/dmd.106.013763","type":"journal-article","created":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T01:22:14Z","timestamp":1170724934000},"page":"806-813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Metabolic Profile of a Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1: An in Vivo and in Vitro Study"],"prefix":"10.1016","volume":"35","author":[{"given":"Loraine","family":"Tirand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Dodeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Dumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Frochot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Maunit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Barberi-Heyob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.106.013763_bib1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/0929867024606731","article-title":"Converting a peptide into a drug: strategies to improve stability and bioavailability","volume":"9","author":"Adessi","year":"2002","journal-title":"Curr Med Chem"},{"key":"10.1124\/dmd.106.013763_bib2","first-page":"951","article-title":"Wild-type p53 gene transfer into mutated p53 HT29 cells improves sensitivity to photodynamic therapy via induction of apoptosis","volume":"24","author":"Barberi-Heyob","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1124\/dmd.106.013763_bib3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bjc.6600682","article-title":"Foscam uptake and tissue distribution in relation to photodynamic efficacy","volume":"88","author":"Cramers","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1124\/dmd.106.013763_bib4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ejmech.2005.04.007","article-title":"The 2-aminoglucosamide motif improves cellular uptake and photodynamic activity of tetraphenylporphyrin","volume":"40","author":"Di Stasio","year":"2005","journal-title":"Eur J Med Chem"},{"key":"10.1124\/dmd.106.013763_bib5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","article-title":"Photodynamic therapy","volume":"90","author":"Dougherty","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/dmd.106.013763_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other disease","volume":"1","author":"Folkman","year":"1995","journal-title":"Nat Med"},{"key":"10.1124\/dmd.106.013763_bib7","first-page":"482","article-title":"Identification and partial characterization of an unusual distribution of the photosensitizer meta-tetrahydroxyphenyl chlorin (temoporfin) in human plasma","volume":"69","author":"Hopkinson","year":"1999","journal-title":"Photochem Photobiol"},{"key":"10.1124\/dmd.106.013763_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbamem.2005.02.003","article-title":"Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels","volume":"1669","author":"Ichikawa","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.106.013763_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0378-5173(02)00682-8","article-title":"Peptide-targeted PEG-liposomes in anti-angiogenic therapy","volume":"254","author":"Janssen","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1124\/dmd.106.013763_bib10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/sj.bjc.6601101","article-title":"Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokinetics","volume":"89","author":"Jones","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1124\/dmd.106.013763_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1011-1344(98)00106-7","article-title":"Relative contributions of apoptosis and random necrosis in tumour response to photodynamic therapy: effect of the chemical structure of Zn(II)-phthalocyanines","volume":"43","author":"Jori","year":"1998","journal-title":"J Photochem Photobiol B"},{"key":"10.1124\/dmd.106.013763_bib12","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1016\/j.bmc.2004.04.022","article-title":"A study of the stability of tri(glucosyloxyphenyl)chlorin, a sensitizer for photodynamic therapy, in human colon tumoural cells: a liquid chromatography and MALDI-TOF mass spectrometry analysis","volume":"12","author":"Laville","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/dmd.106.013763_bib13","series-title":"Mammalian Proteases: A Glossary and Bibliography. 1. Endopeptidases","author":"McDonald","year":"1980"},{"key":"10.1124\/dmd.106.013763_bib14","series-title":"Mammalian Proteases: A Glossary and Bibliography. 2. Exopeptidases","author":"McDonald","year":"1986"},{"key":"10.1124\/dmd.106.013763_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.nucmedbio.2004.01.005","article-title":"In vitro evaluation and biodistribution of a 99mTc-labeled anti-VEGF peptide targeting neuropilin-1","volume":"31","author":"Perret","year":"2004","journal-title":"Nucl Med Biol"},{"key":"10.1124\/dmd.106.013763_bib16","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1023\/A:1018953309913","article-title":"Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum","volume":"10","author":"Powell","year":"1993","journal-title":"Pharm Res (NY)"},{"key":"10.1124\/dmd.106.013763_bib17","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1001\/archopht.122.7.1002","article-title":"Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2","volume":"122","author":"Renno","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1124\/dmd.106.013763_bib18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1358\/dnp.2005.18.10.949485","article-title":"Lysosomal cysteine proteases: structure, function and inhibition of cathepsins","volume":"18","author":"Roberts","year":"2005","journal-title":"Drug News Perspect"},{"key":"10.1124\/dmd.106.013763_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1096\/fj.02-0201com","article-title":"Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling","volume":"17","author":"Rodrigues","year":"2003","journal-title":"FASEB J"},{"key":"10.1124\/dmd.106.013763_bib20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1440-1711.2000.00925.x","article-title":"Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency","volume":"78","author":"Rosenkranz","year":"2000","journal-title":"Immunol Cell Biol"},{"key":"10.1124\/dmd.106.013763_bib21","first-page":"391","article-title":"[Selective occlusion of ocular neovascularization by photodynamic therapy]","volume":"89","author":"Schmidt","year":"1992","journal-title":"Ophthalmologe"},{"key":"10.1124\/dmd.106.013763_bib22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2174\/187152006778226503","article-title":"Recent improvements in the use of synthetic peptides for a selective photodynamic therapy","volume":"6","author":"Schneider","year":"2006","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1124\/dmd.106.013763_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.addr.2003.08.015","article-title":"Targeted photodynamic therapy via receptor mediated delivery systems","volume":"56","author":"Sharman","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.106.013763_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jconrel.2005.11.017","article-title":"A peptide competing with VEGF(165) binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells","volume":"111","author":"Tirand","year":"2006","journal-title":"J Controlled Release"},{"key":"10.1124\/dmd.106.013763_bib25","series-title":"Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis polynucleotides encoding said peptides and methods of use thereof","author":"Tournaire","year":"2001"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624012984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624012984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.106.013763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:26:19Z","timestamp":1739895979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624012984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0090955624012984"],"URL":"https:\/\/doi.org\/10.1124\/dmd.106.013763","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Profile of a Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1: An in Vivo and in Vitro Study","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.106.013763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}